VivoSeq
Other

Reflux

0

Pipeline Programs↗

1

Active Trials↗

4

Companies Involved↗

Reflux is an early-stage landscape with 0 programs across 4 companies. The most active players are Mario Bilić, Eli Lilly, Boehringer Ingelheim.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

62/100

Attrition Rate

29/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

Mario Bilić

1 program

PreclinicalEli Lilly logo

Eli Lilly

1 program

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

17

clinical trials

Completed8 · 47%
Terminated4 · 24%
Unknown status3 · 18%
Recruiting1 · 6%
Withdrawn1 · 6%

Clinical Trials

Trial Activity

17 trials

The Effect of Physiotherapy on Post POEM Reflux
Recruiting·IInstitute for Clinical and Experimental Medicine·N/A·NCT05326113·30 enrolled
Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 3·NCT02211898·180 enrolled
A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes
Completed·NNational Taiwan University Hospital·N/A·NCT00681005·178 enrolled
Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)
Completed·AstraZeneca logoAstraZeneca·Phase 4·NCT00637845·248 enrolled
Effect of Vitis Vinifera Seed Extract on Venous Reflux Time in Varicose Vein
Completed·YYonsei University·Phase 4·NCT05851183·200 enrolled
Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
Completed·MMayo Clinic·N/A·NCT00170001·500 enrolled
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
Completed·MMedical College of Wisconsin·Phase 2·NCT00199953·50 enrolled
A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus
Completed·—·Phase 1·NCT01818570·25 enrolled
The Effect of Topical Anesthesia on the Phonation Process During High-Speed Digital Imaging Laryngoscopy in Patients With Laryngopharyngeal Reflux: A Randomized Double-Blind Placebo-Controlled Crossover Study
Completed·—·Preclinical·NCT07696429·70 enrolled
Bronchial Hyper-responsiveness in Reflux Cough
Terminated·HHull University Teaching Hospitals NHS Trust·Phase 3·NCT00668317·5 enrolled
Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD
Terminated·UUniversity of Rochester·N/A·NCT00624546·24 enrolled
vMII for Measurement of Oesophageal Bolus Transport and Reflux
Terminated·GGuy's and St Thomas' NHS Foundation Trust·N/A·NCT00604942·140 enrolled
Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection
Terminated·LLCMC Health·N/A·NCT02788591·5 enrolled
Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)
Withdrawn·VVirginia Commonwealth University·N/A·NCT02039869
Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy
Unknown status·UUniversitair Ziekenhuis Brussel·Phase 2·NCT02054637·10 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)